TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Telemedicine on Metabolic Control in the Care of Diabetes Mellitus Type 1 Patients in Multiple Doses of Insulin Treatment in Andalusian Community
Brief Summary: To assess the effect of a 6-month telemedicine program (DiabeTIC) in patients with type 1 diabetes mellitus (DM1) and regular metabolic control (HbA1c \<8%) in multi-dose insulin treatment (MDI) measured HbA1c vs. conventional medical care.


Options:
A: Arm Label: Telemedicine; Type: EXPERIMENTAL; Interventions: Behavioral: Telemedicine | Arm Label: Standard treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Telemedicine; Assigned to Arm(s): Telemedicine
B: Arm Label: Routine general practice care; Type: NO_INTERVENTION; Interventions: Behavioral: Structured personal care | Intervention Type: BEHAVIORAL; Name: Structured personal care; Assigned to Arm(s): Routine general practice care
C: Arm Label: Telemedicine group; Type: EXPERIMENTAL; Interventions: Other: Telemedicine group | Arm Label: Conventional group; Type: PLACEBO_COMPARATOR; Interventions: Other: Conventional group | Intervention Type: OTHER; Name: Telemedicine group; Assigned to Arm(s): Telemedicine group | Intervention Type: OTHER; Name: Conventional group; Assigned to Arm(s): Conventional group
D: Arm Label: T2DM patients seen in routine practice; Type: N/A; Interventions: Other: No treatment given | Intervention Type: OTHER; Name: No treatment given; Assigned to Arm(s): T2DM patients seen in routine practice

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Motivational Interviewing to Address Reluctance and Ambivalence in Palliative Care
Brief Summary: Patients with advanced illness and their families confront a number of issues ranging from distressing symptoms to making complex decisions that affect quality of life and survival. Patients and family members struggle with these decisions even more when they feel ambivalence or reluctance. The investigator's overarching goal is to enhance provision of high quality, patient-centered care for patients with advance illness and their families and to reduce burnout among palliative care clinicians. The investigator will apply a well-established approach to achieving clinician/patient alignment in the primary care setting, Motivational Interviewing (MI) to a new population and setting, palliative care.


Options:
A: Arm Label: ICU Usual Care Control; Type: ACTIVE_COMPARATOR; Interventions: Other: ICU Usual Care Control | Arm Label: The PARTNER Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: The PARTNER Intervention | Intervention Type: BEHAVIORAL; Name: The PARTNER Intervention; Assigned to Arm(s): The PARTNER Intervention | Intervention Type: OTHER; Name: ICU Usual Care Control; Assigned to Arm(s): ICU Usual Care Control
B: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Control | Arm Label: Verbal Information and Discussion; Type: EXPERIMENTAL; Interventions: Other: Verbal Information and Discussion | Intervention Type: OTHER; Name: Verbal Information and Discussion; Assigned to Arm(s): Verbal Information and Discussion | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
C: Arm Label: Feedback Group; Type: EXPERIMENTAL; Interventions: Behavioral: Communication Feedback Form for Patients with Serious Illness | Arm Label: Comparison/Usual Care Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Communication Feedback Form for Patients with Serious Illness; Assigned to Arm(s): Feedback Group
D: Arm Label: Clinicians with MI coaching; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Motivational Interviewing | Arm Label: Wait-list control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Wait-list control | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): Clinicians with MI coaching | Intervention Type: BEHAVIORAL; Name: Wait-list control; Assigned to Arm(s): Wait-list control

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Exercise and Exercise Counselling in Hemodialysis Patients: a Randomized Controlled Trial.
Brief Summary: The aim of the study is to determine the effect of functional exercise and training counseling by kinesiotherapist in addition to the basic exercise program of cycling during dialysis on physical performance of dialysis patients.


Options:
A: Arm Label: Standard Dialysis; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Typical Dialysis, Procedure: Exercise | Arm Label: Cold Dialysis; Type: EXPERIMENTAL; Interventions: Procedure: Cold Dialysis, Procedure: Exercise | Intervention Type: PROCEDURE; Name: Cold Dialysis; Assigned to Arm(s): Cold Dialysis | Intervention Type: PROCEDURE; Name: Typical Dialysis; Assigned to Arm(s): Standard Dialysis | Intervention Type: PROCEDURE; Name: Exercise; Assigned to Arm(s): Cold Dialysis, Standard Dialysis
B: Arm Label: pedometer; Type: EXPERIMENTAL; Interventions: Behavioral: pedometer | Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: pedometer; Assigned to Arm(s): pedometer
C: Arm Label: Functional training and cycling; Type: EXPERIMENTAL; Interventions: Other: Functional training and cycling | Arm Label: Cycling; Type: ACTIVE_COMPARATOR; Interventions: Other: Cycling | Intervention Type: OTHER; Name: Functional training and cycling; Assigned to Arm(s): Functional training and cycling | Intervention Type: OTHER; Name: Cycling; Assigned to Arm(s): Cycling
D: Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: activity group; Type: EXPERIMENTAL; Interventions: Device: Exercise training in addition to nutritional support | Intervention Type: DEVICE; Name: Exercise training in addition to nutritional support; Assigned to Arm(s): activity group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of Hypertension
Brief Summary: Raised blood pressure is a common problem in pregnancy. Raised blood pressure and pre-eclampsia affect about one in ten women and are a major cause of death and premature birth in the United Kingdom and worldwide.

Many women have expressed an interest in monitoring their own blood pressure in between antenatal visits but there has been very little research to guide this. The investigators would like to know if the diagnosis and subsequent care of women with raised blood pressure can be improved if women were able to monitor their own blood pressure safely at home. This work will test whether optimising the diagnosis, monitoring and management of raised BP during pregnancy through self-monitoring of BP is effective, acceptable and cost-effective compared to usual care.

The research team have being working with pregnant women, doctors and midwives to develop a simple and accurate method of self-monitoring of blood pressure in pregnancy.

This randomised controlled trial will:

1. Compare self-monitoring with usual care in women at higher risk of hypertension in pregnancy and assess if self-monitoring can identify raised blood pressure earlier.
2. Compare self-monitoring with usual care for women with high blood pressure in pregnancy to see if it leads to lower blood pressure.
3. Assess if self-monitoring is cost-effective.

Pregnant women who chose to take part in these studies will be randomised to either usual care or asked to monitor their own blood pressure during their pregnancy in addition to their usual antenatal care.


Options:
A: Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: remote monitoring group; Type: EXPERIMENTAL; Interventions: Device: remote monitoring | Intervention Type: DEVICE; Name: remote monitoring; Assigned to Arm(s): remote monitoring group
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Device: Self monitoring of blood pressure using Health Gauge Device and monthly monitoring of weight gain | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Self monitoring of blood pressure using Health Gauge Device and monthly monitoring of weight gain; Assigned to Arm(s): Intervention
C: Arm Label: Mercury; Type: NO_INTERVENTION; Interventions: Device: Automated blood pressure recording device Omron HEM 705CP | Intervention Type: DEVICE; Name: Automated blood pressure recording device Omron HEM 705CP; Assigned to Arm(s): Mercury
D: Arm Label: Self-Monitoring of Blood Pressure; Type: EXPERIMENTAL; Interventions: Other: Self-Monitoring of Blood Pressure | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Self-Monitoring of Blood Pressure; Assigned to Arm(s): Self-Monitoring of Blood Pressure

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Empowerment as a Mechanism for Change in Childhood Obesity Prevention
Brief Summary: The Communities for Healthy Living (CHL) program is a family-focused intervention to promote healthy lifestyle behaviors including diet and physical activity among children (age 3-to 5-years) and their families, enrolled in Head Start.


Options:
A: Arm Label: Standard Palatability and Standard Portion Size; Type: EXPERIMENTAL; Interventions: Other: Plain Vegetables Served in 100% Portion Size | Arm Label: Standard Palatability and Larger Portion Size; Type: EXPERIMENTAL; Interventions: Other: Plain Vegetables Served in 200% Portion Size | Arm Label: Enhanced Palatability and Standard Portion Size; Type: EXPERIMENTAL; Interventions: Other: Enhanced Vegetables Served in 100% Portion Size | Arm Label: Enhanced Palatability and Larger Portion Size; Type: EXPERIMENTAL; Interventions: Other: Enhanced Vegetables Served in 200% Portion Size | Intervention Type: OTHER; Name: Plain Vegetables Served in 100% Portion Size; Assigned to Arm(s): Standard Palatability and Standard Portion Size | Intervention Type: OTHER; Name: Plain Vegetables Served in 200% Portion Size; Assigned to Arm(s): Standard Palatability and Larger Portion Size | Intervention Type: OTHER; Name: Enhanced Vegetables Served in 100% Portion Size; Assigned to Arm(s): Enhanced Palatability and Standard Portion Size | Intervention Type: OTHER; Name: Enhanced Vegetables Served in 200% Portion Size; Assigned to Arm(s): Enhanced Palatability and Larger Portion Size
B: Arm Label: Application use arm; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention arm | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intervention arm; Assigned to Arm(s): Application use arm
C: Arm Label: Basic WISE strategy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: WISE (We Inspire Smart Eating) | Arm Label: Enhanced WISE strategy; Type: EXPERIMENTAL; Interventions: Behavioral: WISE (We Inspire Smart Eating) | Intervention Type: BEHAVIORAL; Name: WISE (We Inspire Smart Eating); Assigned to Arm(s): Basic WISE strategy, Enhanced WISE strategy
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Parents Connect for Healthy Living (PConnect), Behavioral: Enhanced Nutrition Support, Behavioral: Media Resources | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Parents Connect for Healthy Living (PConnect); Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Nutrition Support; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Media Resources; Assigned to Arm(s): Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Empowerment as a Mechanism for Change in Childhood Obesity Prevention
Brief Summary: The Communities for Healthy Living (CHL) program is a family-focused intervention to promote healthy lifestyle behaviors including diet and physical activity among children (age 3-to 5-years) and their families, enrolled in Head Start.


Options:
A: Arm Label: Program SI! educational intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Program SI! educational intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Program SI! educational intervention; Assigned to Arm(s): Program SI! educational intervention
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Parents Connect for Healthy Living (PConnect), Behavioral: Enhanced Nutrition Support, Behavioral: Media Resources | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Parents Connect for Healthy Living (PConnect); Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Nutrition Support; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Media Resources; Assigned to Arm(s): Intervention
C: Arm Label: Healthy Lifestyles Group; Type: EXPERIMENTAL; Interventions: Behavioral: Keys to Healthy Family Child Care Homes | Arm Label: Healthy Business Group; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Keys to Healthy Family Child Care Homes | Intervention Type: BEHAVIORAL; Name: Keys to Healthy Family Child Care Homes; Assigned to Arm(s): Healthy Business Group, Healthy Lifestyles Group
D: Arm Label: parent intervention plus gym lessons; Type: EXPERIMENTAL; Interventions: Behavioral: parent-focused intervention, Behavioral: twice weekly gym lessons | Arm Label: gym lessons only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: twice weekly gym lessons | Intervention Type: BEHAVIORAL; Name: parent-focused intervention; Assigned to Arm(s): parent intervention plus gym lessons | Intervention Type: BEHAVIORAL; Name: twice weekly gym lessons; Assigned to Arm(s): gym lessons only, parent intervention plus gym lessons

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Exploratory, Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Year-Old Adults
Brief Summary: The purpose of this study is to assess a trend for the prophylactic efficacy of a single dose of 1\*10\^11 virus particles (vp) of adenovirus serotype 26 respiratory syncytial virus pre-fusion F protein (Ad26.RSV.preF) administered intramuscularly to adults aged 18-50 years in the respiratory syncytial virus (RSV) challenge model in terms of reduction of nasal wash viral load compared to placebo.


Options:
A: Arm Label: RSV cps2 Vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSV cps2 Vaccine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo Vaccine | Intervention Type: BIOLOGICAL; Name: RSV cps2 Vaccine; Assigned to Arm(s): RSV cps2 Vaccine | Intervention Type: BIOLOGICAL; Name: Placebo Vaccine; Assigned to Arm(s): Placebo
B: Arm Label: Vitamin D and gargling; Type: EXPERIMENTAL; Interventions: Dietary Supplement: cholecalciferol (vitamin D3), Behavioral: Gargling | Arm Label: Vitamin D and general health advice; Type: EXPERIMENTAL; Interventions: Dietary Supplement: cholecalciferol (vitamin D3) | Arm Label: Placebo and general health advice; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: Placebo and gargling; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Gargling, Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: cholecalciferol (vitamin D3); Assigned to Arm(s): Vitamin D and gargling, Vitamin D and general health advice | Intervention Type: BEHAVIORAL; Name: Gargling; Assigned to Arm(s): Placebo and gargling, Vitamin D and gargling | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo and gargling, Placebo and general health advice
C: Arm Label: Group 1: Ad26.RSV.preF; Type: EXPERIMENTAL; Interventions: Biological: Ad26.RSV.preF | Arm Label: Group 2: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: BIOLOGICAL; Name: Ad26.RSV.preF; Assigned to Arm(s): Group 1: Ad26.RSV.preF | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Group 2: Placebo
D: Arm Label: RSV LID cp ΔM2-2 Vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSV LID cp ΔM2-2 Vaccine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: RSV LID cp ΔM2-2 Vaccine; Assigned to Arm(s): RSV LID cp ΔM2-2 Vaccine | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Impact of a Nutritional Supplement (Impryl®) on Male Fertility
Brief Summary: Infertility is a worldwide problem and about 10%-15% of all couples will be affected by the inability to have children. In approximately 50% of infertile couples a male factor is involved. Male infertility is of multifactorial origin. In the past decade, the role of oxidative stress on sperm has been researched thoroughly and found to be the problem in 30% to 80% of male infertility cases.

Impryl® is a nutritional supplement mainly consisting of vitamin B, which works on the metabolic system by activating the one carbon cycle and recycling of homocysteine without the use of any direct strong antioxidants.

In this study the investigators want to determine the effectiveness of nutritional supplement Impryl® in men of infertile couples on ongoing pregnancy rate, with or without assisted reproduction technology (ART).


Options:
A: Arm Label: Impryl; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Impryl | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Impryl; Assigned to Arm(s): Impryl | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: DHA plus vitamin E; Type: EXPERIMENTAL; Interventions: Dietary Supplement: vitamin E, Dietary Supplement: DHA | Arm Label: VitaminE plus placebo; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: vitamin E, Other: placebo | Arm Label: placebo plus placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Arm Label: DHA plus placebo; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: DHA, Other: placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin E; Assigned to Arm(s): DHA plus vitamin E, VitaminE plus placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: DHA; Assigned to Arm(s): DHA plus placebo, DHA plus vitamin E | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): DHA plus placebo, VitaminE plus placebo, placebo plus placebo
C: Arm Label: Zinc sulfate; Type: EXPERIMENTAL; Interventions: Dietary Supplement: zinc sulfate | Arm Label: Healthy control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: zinc sulfate; Assigned to Arm(s): Zinc sulfate
D: Arm Label: High dose Vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Ergocalciferol | Arm Label: Low dose Vitamin D; Type: SHAM_COMPARATOR; Interventions: Dietary Supplement: Ergocalciferol | Intervention Type: DIETARY_SUPPLEMENT; Name: Ergocalciferol; Assigned to Arm(s): High dose Vitamin D | Intervention Type: DIETARY_SUPPLEMENT; Name: Ergocalciferol; Assigned to Arm(s): Low dose Vitamin D

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect and Associated Factors of the Clinical Pharmacy Model in the Incidence of Medical Errors in the Hospital Pablo Tobon Uribe- Colombia
Brief Summary: Medication errors are considered by WHO to be a subject that requires attention at all levels of care, in order to reduce the serious and preventable damage related to medication.

These strategies are aimed at the patient's safety policy. In Colombia, at the regulatory level there is no standardized clinical pharmacy model where the role of the clinical pharmacist is described extensively and in detail, and in addition, data are unknown of the scope or direct effect of the incorporation of this model in the assistance in the results of health care.

The Hospital Pablo Tobón Uribe, it is a highly complex institution in Medellin (Colombia), certified by Join Comission International (JCI), which requires the continuous interaction of the pharmacist in patient care, in order to avoid medication errors and contribute to patient safety indicators. In this sense, the hospital structured and implemented a clinical pharmacy model that establishes the activities of the pharmacist incorporated into the care team in the patient attention. Today this model is applied in the institution, however, it is necessary to know the effect of its application in the solution of drug-related problems (DRPs) or a negative outcome related to medicine. The objective of this study is to know the effect on patient safety of a clinical pharmacy model in a hospital of high complexity and framed in the WHO initiative to reduce these errors of medication.


Options:
A: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease | Intervention Type: BEHAVIORAL; Name: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease; Assigned to Arm(s): 2
B: Arm Label: Patients without intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Clinical pharmacy model | Arm Label: Patients with intervention; Type: EXPERIMENTAL; Interventions: Other: Clinical pharmacy model | Intervention Type: OTHER; Name: Clinical pharmacy model; Assigned to Arm(s): Patients with intervention, Patients without intervention
C: Arm Label: Minimal intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Minimal intervention | Arm Label: Enhanced intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Minimal intervention; Assigned to Arm(s): Minimal intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Intervention; Assigned to Arm(s): Enhanced intervention
D: Arm Label: I; Type: EXPERIMENTAL; Interventions: Other: Drug review 80+ -To reduce usage of hospital care | Arm Label: C; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Drug review 80+ -To reduce usage of hospital care; Assigned to Arm(s): I

Answer: B